Defining optimal treatment for stage II colon cancer: Does decision analysis help?

Gastroenterology

Volumn 117, Issue 4, 1999, Pages 1005-1008

  Schrag, D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; COLON CARCINOMA; COLON SURGERY; COST BENEFIT ANALYSIS; EDITORIAL; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0032882322     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70359-8     Document Type: Editorial

References (7)

1. P Michel V Merle A Chiron P Ducrotte B Paillot P Hecketsweiler P. Czernichow Postoperative management of stage II/III colon cancer: a decision analysis Gastroenterology 117 1999 784 793
2. NIH Consensus Conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1450
3. International Multicentre Pooled Analysis of B2 Colon Cancer Trials IMPACT B2 Investigators Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer J Clin Oncol 17 1999 1356 1363
4. E Mamounas S Wieand N Wolmark HD Bear JN Atkins K Song J Jones H. Rockette Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four national surgical adjuvant breast and bowel project adjuvant studies J Clin Oncol 17 1999 1349 1355
5. D. Harrington The tea leaves of small trials J Clin Oncol 17 1999 1336 1338
6. J Siegel M Weinstein L Russell M. Gold Recommendations for reporting cost-effectiveness analyses JAMA 16 1996 1339 1341
7. M Weinstein J Siegel M Gold MS Kamlet CB. Rossell Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1996 1253 1258